Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Wolden
    Wolden
  2. La Quaglia
    La Quaglia
  3. Lin
    Lin
  4. Herr
    Herr
  5. Bochner
    Bochner
  6. Dalbagni
    Dalbagni
  7. Donat
    Donat
  8. Ganly
    Ganly
  9. Barker
    Barker
  10. Cheung
    Cheung

Groups

  1. Center for Hematologic Malignancies (31)
  2. Pediatric Leukemia (31)
  3. Surgery (18)
  4. Pediatrics, Department of (17)
  5. Survivorship Research (14)
  6. Radiation Oncology, Department of (13)
  7. Department of Pathology and Laboratory Medicine (6)
  8. Epidemiology and Biostatistics (6)
  9. GSK Faculty (5)
  10. Hematologic Malignancies Service (5)
Search Within
  1. "Pediatric Leukemia"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (3)
  3. Book Section (1)
  4. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Pediatric Leukemia (31)
  3. Surgery (18)
  4. Pediatrics, Department of (17)
  5. Survivorship Research (14)
  6. Radiation Oncology, Department of (13)

More Groups

People
  1. Suzanne Wolden (12)
  2. Michael La Quaglia (9)
  3. Oscar Lin (6)
  4. Gilad Cohen (5)
  5. Harry Herr (4)
  6. Peter Steinherz (4)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Brachytherapy (7)
  2. Lancet Oncology (6)
  3. Journal of Urology (5)
  4. Journal of Molecular Diagnostics (2)
  5. Lancet (2)
  6. American Journal of Pathology (1)

More Publications

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): A randomised, open-label, phase 3 trial from the Children's Oncology Group
    Journal Article

    Gupta, A. A.; Xue, W.; Harrison, D. J.; Hawkins, D. S.; Dasgupta, R.; Wolden, S.; Shulkin, B.; Qumseya, A.; Routh, J. C.; MacDonald, T.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Proton pencil beam scanning craniospinal irradiation (CSI) with a single posterior brain beam: Dosimetry and efficiency
    Journal Article

    Hu, L.; Zhai, A.; Chen, Q.; Puri, V.; Chen, C. C.; Yu, F.; Fox, J.; Wolden, S.; Yang, J.; Simone, C. B. 2nd; more...
    Medical Dosimetry (2024)

    Fulltext@MSK | Save
  • Final results of a phase I trial of WST-11 (TOOKAD Soluble) vascular-targeted photodynamic therapy for upper tract urothelial carcinoma
    Journal Article

    Yip, W.; Sjoberg, D. D.; Nogueira, L. M.; Tracey, A. T.; Alvim, R. G.; Reisz, P. A.; Demac, Q.; Benfante, N. E.; Vanden Berg, R. W.; Kim, K.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): A multicentre phase 1-2 study
    Journal Article

    Geoerger, B.; Zwaan, C. M.; Marshall, L. V.; Michon, J.; Bourdeaut, F.; Casanova, M.; Corradini, N.; Rossato, G.; Farid-Kapadia, M.; Shemesh, C. S.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): A Children's Oncology Group prospective study
    Journal Article

    Spunt, S. L.; Million, L.; Chi, Y. Y.; Anderson, J.; Tian, J.; Hibbitts, E.; Coffin, C.; McCarville, M. B.; Randall, R. L.; Parham, D. M.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Novel intraoperative radiotherapy utilizing prefabricated custom three-dimensionally printed high-dose-rate applicators
    Journal Article

    Imber, B. S.; Wolden, S. L.; Stambuk, H. E.; Matros, E.; Wexler, L. H.; Drew, A. S.; Rosen, E. B.; Ganly, I.; Cohen, G. N.; Damato, A. L.
    Brachytherapy (2019)

    Fulltext@MSK | Save
  • The American Brachytherapy Society consensus statement on intraoperative radiation therapy
    Guidelines

    Tom, M. C.; Joshi, N.; Vicini, F.; Chang, A. J.; Hong, T. S.; Showalter, T. N.; Chao, S. T.; Wolden, S.; Wu, A. J.; Martin, D.; more...
    Brachytherapy (2019)

    Fulltext@MSK | Save
  • Ultra-rapid EGFR mutation assessment in lung adenocarcinoma without prior DNA extraction
    Meeting Abstract

    Arcila, M. E.; Salazar, P. A.; Rijo, I.; Elezovic, D.; Rekhtman, N.; Buonocore, D. J.; Lin, O.; Chaft, J. E.; Ladanyi, M.; Nafa, K.
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal
    Journal Article

    King, M. T.; Voros, L.; Cohen, G. N.; Lanning, R. M.; Ganly, I.; O'Suoji, C. C.; Wolden, S. L.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save